Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Biocompatible Sensor Implant Allows Brain Monitoring Through Development

By HospiMedica International staff writers
Posted on 15 Jan 2025

Advanced electronics have been in development for several decades, resulting in a vast collection of circuit designs. More...

However, most of these transistor and amplifier technologies are incompatible with human physiology. In traditional bioelectronics, complementary transistors are made from different materials to handle the varying polarities of signals. These designs, while functional, are often rigid and cumbersome and present a risk of toxicity when implanted in sensitive areas. Now, researchers have developed a biocompatible sensor implant by embedding transistors in a soft, conformable material to monitor neurological functions through successive stages of a patient’s development.

In a paper published in Nature Communications, scientists from the University of California, Irvine (Irvine, CA, USA) and Columbia University (New York, NY, USA) described their creation of complementary, internal, ion-gated, organic electrochemical transistors. These transistors are more chemically, biologically, and electronically compatible with living tissues compared to rigid, silicon-based technologies. Medical devices based on these transistors can function in delicate parts of the body and adapt to organ structures, even as they grow. The asymmetric design of the transistors allows them to operate using a single, biocompatible material.

By arranging the transistors into a smaller, single-polymer material, the fabrication process is greatly simplified, enabling large-scale production. This innovation opens up possibilities to expand the technology beyond its initial use in neurology to virtually any biopotential process. Additionally, the device can be implanted in a developing animal and can withstand changes in tissue structures as the organism grows—something that rigid, silicon-based implants cannot do. Complementary, internal, ion-gated, organic electrochemical transistors will significantly broaden the scope of bioelectronics, enabling the development of devices that traditionally relied on bulky, non-biocompatible components.

“A transistor is like a simple valve that controls the flow of current. In our transistors, the physical process that controls this modulation is governed by the electrochemical doping and de-doping of the channel,” said first author Duncan Wisniewski, Columbia University Ph.D. “By designing devices with asymmetrical contacts, we can control the doping location in the channel and switch the focus from negative potential to positive potential. This design approach allows us to make a complementary device using a single material.”


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gas Analyzer
GE SAM
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.